|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Assets | ||||
| Cash | ||||
| Cash and cash equivalents | ||||
| Deferred offering costs | ||||
| Prepaid expenses | ||||
| Total current assets | ||||
| Asset, Held-in-Trust, Noncurrent | ||||
| Total assets | ||||
| Liabilities and Shareholders’ Equity | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Nonrelated Party | ||||
| Related Party | ||||
| Due to related party | ||||
| Other payable – related party (Note 5) | ||||
| Accrued offering costs | ||||
| Total current liabilities | ||||
| Total liabilities | ||||
| Ordinary shares subject to possible redemption, 6,000,000 shares at redemption value of $10.25 and $10.07 per share as of June 30, 2026 and December 31, 2025, respectively | ||||
| Shareholders’ Equity: | ||||
| Ordinary shares, $0.000075 par value; 266,666,666 shares authorized; 2,427,500 shares issued and outstanding as of June 30, 2026 and December 31, 2025 (excluding 6,000,000 shares subject to possible redemption) | ||||
| Additional paid-in capital | ||||
| Retained earnings | ||||
| Total shareholders’ equity | ||||
| Total Liabilities and Shareholders’ Equity |
Loading...
